193 related articles for article (PubMed ID: 33315951)
1. A conserved role for AMP-activated protein kinase in NGLY1 deficiency.
Han SY; Pandey A; Moore T; Galeone A; Duraine L; Cowan TM; Jafar-Nejad H
PLoS Genet; 2020 Dec; 16(12):e1009258. PubMed ID: 33315951
[TBL] [Abstract][Full Text] [Related]
2. A
Talsness DM; Owings KG; Coelho E; Mercenne G; Pleinis JM; Partha R; Hope KA; Zuberi AR; Clark NL; Lutz CM; Rodan AR; Chow CY
Elife; 2020 Dec; 9():. PubMed ID: 33315011
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
5. Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a
Rodriguez TP; Mast JD; Hartl T; Lee T; Sand P; Perlstein EO
G3 (Bethesda); 2018 Jul; 8(7):2193-2204. PubMed ID: 29735526
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
7. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
8. Drug screens of
Iyer S; Mast JD; Tsang H; Rodriguez TP; DiPrimio N; Prangley M; Sam FS; Parton Z; Perlstein EO
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31615832
[No Abstract] [Full Text] [Related]
9. NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology.
Pandey A; Adams JM; Han SY; Jafar-Nejad H
Cells; 2022 Mar; 11(7):. PubMed ID: 35406718
[No Abstract] [Full Text] [Related]
10. Tracing the NGLY1 footprints: insights from Drosophila.
Pandey A; Jafar-Nejad H
J Biochem; 2022 Feb; 171(2):153-160. PubMed ID: 34270726
[TBL] [Abstract][Full Text] [Related]
11. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.
Yang K; Huang R; Fujihira H; Suzuki T; Yan N
J Exp Med; 2018 Oct; 215(10):2600-2616. PubMed ID: 30135079
[TBL] [Abstract][Full Text] [Related]
12. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
13. Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency.
Hall PL; Lam C; Alexander JJ; Asif G; Berry GT; Ferreira C; Freeze HH; Gahl WA; Nickander KK; Sharer JD; Watson CM; Wolfe L; Raymond KM
Mol Genet Metab; 2018 May; 124(1):82-86. PubMed ID: 29550355
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific regulation of BMP signaling by
Galeone A; Han SY; Huang C; Hosomi A; Suzuki T; Jafar-Nejad H
Elife; 2017 Aug; 6():. PubMed ID: 28826503
[TBL] [Abstract][Full Text] [Related]
15. Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.
Haijes HA; de Sain-van der Velden MGM; Prinsen HCMT; Willems AP; van der Ham M; Gerrits J; Couse MH; Friedman JM; van Karnebeek CDM; Selby KA; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Mol Genet Metab; 2019 Aug; 127(4):368-372. PubMed ID: 31311714
[TBL] [Abstract][Full Text] [Related]
16. GlcNAc-Asn is a biomarker for NGLY1 deficiency.
Mueller WF; Zhu L; Tan B; Dwight S; Beahm B; Wilsey M; Wechsler T; Mak J; Cowan T; Pritchett J; Taylor E; Crawford BE
J Biochem; 2022 Feb; 171(2):177-186. PubMed ID: 34697629
[TBL] [Abstract][Full Text] [Related]
17. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
Suzuki T
J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
[TBL] [Abstract][Full Text] [Related]
18. Novel NGLY1 gene variants in Chinese children with global developmental delay, microcephaly, hypotonia, hypertransaminasemia, alacrimia, and feeding difficulty.
Abuduxikuer K; Zou L; Wang L; Chen L; Wang JS
J Hum Genet; 2020 Apr; 65(4):387-396. PubMed ID: 31965062
[TBL] [Abstract][Full Text] [Related]
19. An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency.
Hope KA; Berman AR; Peterson RT; Chow CY
PLoS Genet; 2022 Jun; 18(6):e1010228. PubMed ID: 35653343
[TBL] [Abstract][Full Text] [Related]
20. JF1/B6F1 Ngly1
Asahina M; Fujinawa R; Fujihira H; Masahara-Negishi Y; Andou T; Tozawa R; Suzuki T
Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(2):89-102. PubMed ID: 33563880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]